Millipore Exploring Alternatives Following News of Acquisition Bid

Millipore said late last night that its board of directors is evaluating "strategic alternatives to enhance shareholder value," including a potential merger or sale of the company.

Millipore's statement comes two days after Bloomberg reported that Thermo Fisher Scientific had made a $6 billion bid for the firm.

Millipore confirmed that it has hired Goldman Sachs as its financial advisor and Cravath, Swaine & Moore as its legal advisor to assist the board in its evaluation.

Millipore also said that it has not set a timetable for completing the evaluation and cannot assure that it will lead to any transaction.

In early Wednesday trade on the New York Stock Exchange, shares of Millipore were up 3 percent at $91.50. Its shares are up 28 percent for the week.

Unique database of Bioinformatics tools and softwares - from SciClips

Sciclips has recently launched a unique database of bioinformatics
tools and software for reserchers. This database contains links
to more than 2000 web-based bioinformatics and software tools
for DNA, RNA, proteins, genomics, proteomics, drug discovery
research and many more.

This database is the largest online collection for bioinformatics tools
and software that is freely available to the researchers.
This one-stop extensive bioinformatics database will help researchers
in retrieving, analysing the most relevant biological data and
extracting information from them efficiently for genomics,
proteomics and drug discovery and other areas of research.

Bioinformatics Tools and Database Protocols